Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment Among High-Risk Patients With Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) Infection
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac186
Abstract: Abstract Summary Retrospective analysis of the post–propensity score (PS)–matched cohort of 8426 outpatients balanced in clinical and demographic covariates showed that treatment with casirivimab-imdevimab monoclonal antibody was effective against the SARS-CoV-2 Delta variant to reduce… read more here.
Keywords: imd mab; cas imd; delta variant; casirivimab imdevimab ... See more keywords
Omicron breakthrough infection in a kidney‐transplant patient given pre‐exposition casirivimab and imdevimab monoclonal antibodies
Sign Up to like & getrecommendations! Published in 2022 at "Transplant Infectious Disease"
DOI: 10.1111/tid.13803
Abstract: for to pre-exposition neutralizing casirivimab and imdevimab monoclonal antibodies in immunosuppressed patients with no or weak response to three doses of SARS-CoV-2 read more here.
Keywords: pre exposition; casirivimab imdevimab; omicron breakthrough; monoclonal antibodies ... See more keywords